Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation

Abstract Background There are accumulating type 2 diabetes patients who have osteoporosis simultaneously. More effective therapeutic strategies should be discovered. Biochanin A (BCA) has been indicated that can play a role in improving metabolic disorders of type 2 diabetes and preventing osteoporo...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Qi He, Junzheng Yang, Weijian Chen, Zhaofeng Pan, Baihao Chen, Jiaxu Zeng, Nenling Zhang, Yuewei Lin, Chuyi Chen, Jiacong Xiao, Miao Li, Shaocong Li, Haibin Wang, Peng Chen
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2024-01-01
Serie:	BMC Complementary Medicine and Therapies
Ämnen:	Biochanin A Type 2 diabetic osteoporosis Osteoclasts Oxidative stress MAPK signaling pathway
Länkar:	https://doi.org/10.1186/s12906-023-04332-x
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!